MyFinsight
Home
Blog
About
Back
Income Statement
Kyverna Therapeutics, Inc. (KYTX)
Kyverna Therapeutics, Inc. (KYTX)
source: myfinsight.com
Net loss and other
comprehensive loss
-$38,365K
(8.87%↑ Y/Y)
Interest income
$1,929K
(-18.40%↓ Y/Y)
Net loss
-$38,319K
(8.94%↑ Y/Y)
Total other
comprehensive loss
-$46K
(-142.11%↓ Y/Y)
Total other income,
net
$1,237K
(-46.89%↓ Y/Y)
Interest expense
$674K
(4714.29%↑ Y/Y)
Other expense, net
-$18K
(14.29%↑ Y/Y)
Loss from operations
-$39,556K
(10.93%↑ Y/Y)
Unrealized loss on
available-for-sale marketable...
-$46K
(-142.11%↓ Y/Y)
Total operating
expenses
$39,556K
(-10.93%↓ Y/Y)
Research and development
$24,788K
(-30.79%↓ Y/Y)
General and
administrative
$14,768K
(71.84%↑ Y/Y)
Back